Study highlights industry's dominance in cancer research amid federal funding cuts

A new study reveals that the biopharma industry has overtaken the federal government as the primary driver of clinical trial research in oncology. The shift underscores the potential impact of proposed cuts to federal research funding under the current administration. The findings suggest that industry priorities now largely shape the cancer research landscape.